Affiliation: Radiation Oncologist, Sanofi Clinical Study Unit, Turkey & Middle East Cluster, Turkey.
This review article discusses the current challenges and future trends on research and development (R&D) activities. Development of a new medicine becomes more complicated, challenging and expensive as well as more risky because of further obstacles during the registration. Clinical Research phases of R&D consume more than two thirds of the development cost. So sponsors will be veered towards business operations that offer cost savings, consistency, quality, and enhancements in clinical trial productivity. Gigantic changes in technology bring more challenges and opportunities to industry, clinical researchers and healthcare givers. Joint efforts by sponsors/contract research organizations, research institutes, universities and regulatory authorities are needed to shape the clinical research in the future, especially the Middle East and North Africa region.